NCT04272008View on ClinicalTrials.gov

The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
Contraception
Interventions
DRUG

Segesterone Acetate and Ethinyl Estradiol

Annovera taken alone

OTHER

Tampon

Annovera with tampon use

Trial Locations (2)

19104

University of Pennsylvania Women's Health Clinical Research Center, Philadelphia

G1P OA2

Syneos Health, Québec

Sponsors

Lead Sponsor

TherapeuticsMD
All Listed Sponsors
lead

TherapeuticsMD

INDUSTRY

NCT04272008 - The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol | Biotech Hunter | Biotech Hunter